ADIM
VCEL icon

Alpha DNA Investment Management’s Vericel Corp VCEL Stock Holding History

Alpha DNA Investment Management’s Portfolio VCEL Stock Details VCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-89
Closed -$4K – 632
2021
Q1 		$4K Buy
+89
New +$4.03K ﹤0.01% 429

Other funds holding VCEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Alpha DNA Investment Management's VCEL Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Vericel Corp (VCEL) in Q2 2021, closing a stake of 89 shares — an estimated $4K sold.

Alpha DNA Investment Management first reported a position in VCEL in Q1 2021 and held it in 1 quarter. The position peaked at $4K in Q1 2021. 205 funds tracked by Wall St. Rank hold VCEL as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Vericel Corp position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 89 Vericel Corp shares in Q2 2021, an estimated $4K.
  • Alpha DNA Investment Management first reported a position in Vericel Corp in Q1 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's Vericel Corp position peaked at $4K in Q1 2021.
  • 205 funds tracked by Wall St. Rank held Vericel Corp as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.